Natural Capsules (NATCAPSUQ) | Stock Overview & Key Data
Natural Capsules Performance Comparison
Stock Range
Today's Range
Low: ₹187.30
High: ₹215.00
on September 18, 2025
52 Week Range
Low: ₹164.00
High: ₹274.75
on March 26, 2025
on June 4, 2025
All-Time High: ₹274.75 on June 2, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR2.0B
EPS
-5.42
P/E Ratio (TTM)
337.98
Forward P/E
N/A
P/B Ratio
0.84
PEG Ratio
-0.36
Div. Yield
N/A
ROE
0.24%
Beta
-0.260
Debt to Equity
40.91
Financial Highlights
Profitability
Gross Margin
47.85%
Operating Margin
-8.61%
Profit Margin
-3.18%
Returns and Earnings
Return on Assets (TTM)
0.15%
Return on Equity (TTM)
0.24%
EBITDA
INR148.7M
Net Income (TTM)
INR-55.7M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR169.23
Quarterly Revenue Growth (YoY)
15.40%
Quarterly Earnings Growth (YoY)
15.37%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Natural Capsules NATCAPSUQ | 1.98B Small-cap | -3.25% | -6.63% | -11.63% | -3.21% | -24.16% | -24.16% | -24.16% | -24.16% |
| Sun Pharmaceutical SUNPHARMA | 3.94T Large-cap | 1.68% | -0.77% | -1.82% | -4.93% | -14.27% | -13.16% | 75.90% | 230.89% |
| Divi's Laboratories DIVISLAB | 1.62T Large-cap | 0.33% | -1.83% | -7.44% | 6.71% | -0.35% | 11.02% | 66.13% | 97.71% |
| Innova Captab INNOVACAP | 49.37B Small-cap | -1.03% | -4.59% | -1.52% | 9.74% | -22.13% | 8.68% | 59.57% | 59.57% |
| Sequent Scientific SEQUENT | 46.87B Small-cap | 4.38% | 8.86% | -1.81% | 45.82% | 3.55% | 10.24% | 79.53% | 30.69% |
| Sun Pharma Advanced SPARC | 46.74B Small-cap | 0.25% | 0.48% | -9.74% | 23.07% | -28.10% | -33.93% | -33.55% | -14.23% |
Ownership & Short Interest
Insider Ownership
65.11%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
10K
Average 90-Day Volume
9K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is NATCAPSUQ's 52-week high and low?
- In the last 52 weeks, Natural Capsules reached a high of ₹274.75 (on June 4, 2025) and a low of ₹164.00 (on March 26, 2025).
- What is the market cap and P/E ratio for NATCAPSUQ?
- Curious about Natural Capsules's size and valuation? Its market capitalization stands at 1.98B. When it comes to valuation, the P/E ratio (trailing twelve months) is 337.98, and the forward P/E (looking ahead) is N/A.
- Does NATCAPSUQ pay dividends? If so, what's the yield?
- As for dividends, Natural Capsules isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Natural Capsules's main competitors or similar companies to consider before investing?
When looking at Natural Capsules, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.94T Healthcare Drug Manufacturers - Specialty & Generic -13.16% 75.90% Divi's Laboratories
DIVISLAB1.62T Healthcare Drug Manufacturers - Specialty & Generic 11.02% 66.13% Innova Captab
INNOVACAP49.37B Healthcare Drug Manufacturers - Specialty & Generic 8.68% 59.57% Sequent Scientific
SEQUENT46.87B Healthcare Drug Manufacturers - Specialty & Generic 10.24% 79.53% Sun Pharma Advanced
SPARC46.74B Healthcare Drug Manufacturers - Specialty & Generic -33.93% -33.55% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Natural Capsules Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Natural Capsules's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 0.24%, the Debt to Equity ratio from the most recent quarter is 40.91, and its Gross Profit Margin stands at 47.85%.
- What is the recent revenue and earnings growth for NATCAPSUQ?
- Looking at Natural Capsules's growth, its revenue over the trailing twelve months (TTM) was INR2B. Compared to the same quarter last year (YoY), quarterly revenue grew by 15.40%, and quarterly earnings saw a YoY growth of 15.37%.
- How much of NATCAPSUQ stock is held by insiders and institutions?
- Wondering who owns Natural Capsules stock? Company insiders (like executives and directors) hold about 65.11% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.